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Abstract
Fructose consumption has been linked to obesity and increased hepatic de novo 
lipogenesis (DNL). Excessive caloric intake often confounds the results of fruc-
tose studies, and experimental diets are generally low-fat diets, not representative 
for westernized diets. Here, we compared the effects of dietary fructose with those 
of dietary glucose, in adult male and female mice on a starch-containing moder-
ate high–fat (HF) diet. After 5 weeks fattening on a HF high-glucose (HF-G) diet, 
mice were stratified per sex and assigned to one of the three intervention diets for 
6 weeks: HF high fructose (HF-F), HF with equimolar glucose and fructose (HF-
GF), or HF-G. Bodyweight (BW) and food intake were measured weekly. Indirect 
calorimetry was performed on week 5; animals were sacrificed in food-deprived state 
on week 6. Data were analyzed within sex. BW gain was similar among animals on 
the HF-G, HF-GF, and HF-F diets. Cumulative food intake was slightly lower in 
HF-F animals (both sexes). However, energy expenditure was not affected, or were 
circulating insulin and glucose concentrations, and hepatic triglyceride levels at end-
point. Hepatic gene expression analysis showed only minor alterations in hexokinase 
and glycolysis-related expression in males, and no alterations in sugar transporters, 
or DNL-related enzymes. In females, no consistent alterations in hepatic or small 
intestine gene expression were seen. Concluding, partial or complete replacement 
of dietary glucose with fructose does not increase caloric intake, and does not affect 
BW, hepatic triglyceride levels, or insulin concentrations in male and female mice 
on a moderate high–fat diet.
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1 |  INTRODUCTION
The worldwide increase in prevalence of obesity is a major 
health concern (WHO, 2018). The cause of this increase is 
considered to be multifactorial, with dietary habits and a 
sedentary life style as two main contributors. In addition, it 
has been hypothesized in the early 2000s that the increase in 
obesity and its related health problems are caused by a rise 
in fructose consumption, in particular by fructose coming 
from beverages (Bray, Nielsen, & Popkin, 2004). A decade 
later, Bray et al. (still) state that the consumption of sug-
ar-sweetened beverages is contributing to the high incidence 
of obesity, and that fructose “has critical adverse effects” 
(Bray & Popkin, 2014). Others also suggested that fructose 
exerts detrimental health effects, much worse than caloric 
equivalents, and state that its effects resemble those of al-
cohol (Lustig, 2013). However, this theory is controversial, 
as several research groups suggest that it is not the increased 
sugar or fructose consumption per se that is contributing to 
the pandemic of obesity, but the overall high caloric intake 
(Sievenpiper et al., 2014; Tappy, 2012; White, 2013).
Glucose and fructose are both monosaccharides, have the 
same molecular weight, yet the structural difference causes 
the monosaccharides to be absorbed and metabolized differ-
ently, for instance, using different specific intestinal trans-
porters. Cellular metabolism differs in the first steps, with 
glucose breakdown via glycolysis being regulated by phos-
phofructokinase (PFK), while this step is bypassed in the 
breakdown of fructose (Michal & Schomborg, 2012; Tappy 
& Le, 2010).
Activity of PFK depends on the energy level of the cell. 
When the latter is high, ATP and citrate levels are high, in-
hibiting PFK activity (Tappy & Le, 2010). KHK activity, 
however, is not regulated by the energy status of the cell 
(Tappy & Le, 2010). Therefore, it is believed that in fed 
conditions fructose is directed toward de novo lipogenesis 
(DNL), whereas glucose is directed to glycogenesis (Lustig, 
2010). This is used as explanation for hepatic lipid accu-
mulation in studies with fructose supplementation in the 
drinking water. Others, however, showed that fructose also 
contributes to glycogenesis (Delgado et al., 2013). Scientific 
evidence underlying the potential adverse health effects of 
fructose is often derived from animal studies, yet the results 
of these studies are often difficult to translate to the human 
situation. Fructose in animal studies is generally given in 
very high doses (up to 60 energy percent (en%) from fruc-
tose) and the animals are on a low-fat dietary background. 
In contrast, the contribution of fructose to total energy in the 
human diet is about 9% (median intake in The Netherlands 
(Sluik, Engelen, & Feskens, 2015) and the United States 
(Sun, Anderson, Flickinger, Williamson-Hughes, & Empie, 
2011)), and 17.8% for the 95th percentile fructose con-
sumption (Sun et al., 2011). Moreover, the low-fat dietary 
background in most animal studies is also not representative 
for the human situation; for example, in The Netherlands the 
median contribution of fat to total energy intake in adults 
is approximately 34% (van Rossum, Fransen, Verkaik-
Kloosterman, Buurma-Rethans, & Ocké, 2011). In addition, 
most animal studies investigating fructose use young, nor-
mal weight animals. However, this is scarcely representative 
of the human population that is increasingly overweight and 
obese. Therefore, a period of fattening before the start of 
an animal study will result in a better representation of the 
current human situation.
There is accumulating evidence that sex differences exist 
in the response to fructose. Several human intervention stud-
ies have shown that the effects of fructose are attenuated in 
females. Acute fructose consumption leads to higher uric 
acid and lactate responses in males than in females (Panda 
et al., 1991) and enhanced hepatic DNL stimulation (Tran et 
al., 2010). In addition, the effects of fructose seem blunted in 
females compared with males, as seen with 6 days of fructose 
overfeeding (Couchepin et al., 2008) and after a 6-week fruc-
tose diet intervention with fructose supplementation (Bantle, 
Raatz, Thomas, & Georgopoulos, 2000). Several studies in an-
imal models focus mainly on the effects of long-term fructose 
intake on liver health. Female mice are more susceptible to 
liver damage than males when their drinking water is supple-
mented with 30% fructose for 16 weeks, even though males 
have higher weight gain (Spruss et al., 2012). Liver weight and 
visceral adiposity increase more in female rats compared with 
their male counterparts with a fructose intervention of 9 weeks; 
however, in males, insulin sensitivity and blood pressure are 
affected (Koricanac et al., 2013). Underlying alterations in 
hepatic metabolism by 2 weeks fructose supplementation are 
more severe in females, and mediated by hepatocyte nuclear 
factor 4 (HNF4), whereas in males the reduction in peroxi-
some proliferator-activated receptor α (PPARα) causes the 
alterations in liver (Vilà et al., 2011). However, in all these 
studies fructose was provided in the drinking water, causing 
an increased liquid intake and a decreased food intake, which 
cumulatively resulted in an alteration in the ratio of carbohy-
drate intake to fat intake, as well as in a net increase in caloric 
intake in the fructose groups. Therefore, the effects cannot 
simply be regarded as the effects of fructose as such, as they 
may result from a higher caloric intake.
The aim of this study was, therefore, to elucidate the effects 
of dietary fructose, glucose, and glucose–fructose in a 1:1 ratio 
(all in dietary isocaloric amounts) on bodyweight development 
and hepatic gene expression, in mice on a moderate high–fat 
diet. Fructose and glucose were administered as part of the 
pelletized diet, to circumvent the confounding effects of over-
consumption of fructose in the drinking water. The diet had a 
moderate high–fat content and contained starch, to provide a 
relevant dietary context to the monosaccharides. The diet with 
glucose and fructose in a 1:1 ratio, representing the common 
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dietary sugar sucrose, was used because of dietary relevance, 
and because an interaction of glucose and fructose on gene 
expression in the liver has been reported (Hamblin, Ozawa, 
Jefferds, & Mariash, 1989). Moreover, the diets were adminis-
tered to both males and females to study whether the effects of 
this intervention is affected by sex, and in animals exposed to a 
moderate high–fat diet before the intervention, for the induction 
of a metabolic phenotype that is more representative of an indi-
vidual, currently in a Western society.
2 |  MATERIALS AND METHODS
The experiment was performed according to the Dutch Animal 
Experimentation Act (1996). The experimental protocol was 
approved by the Animal Welfare Committee of Wageningen 
University, Wageningen, The Netherlands (DEC 2010115.d).
2.1 | Animals & experimental procedure
Thirty male and thirty female C57BL/6JOlaHsd mice of 
9 weeks of age were purchased from Harlan Laboratories 
(Horst, The Netherlands). Mice were individually housed 
in Makrolon II cages with standard bedding of wood chips 
and shavings, with ad libitum access to food and water and 
were maintained under controlled environmental conditions 
(temperature 21  ±  1°C; relative humidity 52.5  ±  2.5%; 
12 hr–12 hr light–dark cycle, lights on at 5.00 hr). Animals 
were fed a semisynthetic moderate high–fat (35.9 en% fat) 
high-glucose diet (HF-G; Table 1) obtained from Research 
Diet Services B.V. (Wijk bij Duurstede, The Netherlands). 
This diet is an adaptation of the published BIOCLAIMS 
high-fat diet (Hoevenaars et al., 2012), which is known 
for the induction of insulin resistance (Voigt, Agnew, 
Schothorst, Keijer, & Klaus, 2013). After 5 weeks of fat-
tening, the animals were stratified by bodyweight and as-
signed to one of three dietary groups (n = 10 per group, 
per sex): a moderate high–fat high-glucose (HF-G) diet, a 
moderate high–fat glucose and fructose (HF-GF) diet, or 
a moderate high–fat high-fructose (HF-F) diet; and these 
diets only differed in their monosaccharides composition. 
The detailed dietary compositions can be found in Table 
1. Given the monosaccharide content, the diets contained: 
28.6 en% glucose and 0 en% fructose (HF-G), 14.3 en% 
glucose and 14.3 en% fructose (HF-GF), and 0 en% glucose 
and 28.6 en% fructose (HF-F). All diets contained starch 
(15.3 en%). The calculation of the required group size was 
based on past experience with the detection of statistically 
significant diet-induced alterations in molecular markers. 
The dietary intervention lasted for a total of 6 weeks, and 
bodyweight and food intake were determined weekly in the 
morning.
2.2 | Indirect calorimetry
On week 5 of the intervention, animals were placed into a 
PhenoMaster Indirect Calorimetry System (TSE Systems, Bad 
Homburg, Germany). Rates of oxygen consumption and car-
bon dioxide production were measured for each animal once 
every 12 min. O2 consumption, CO2 production, and activity 
were measured as previously described (Hoevenaars et al., 
2013). Energy expenditure was calculated every 12 min (pre-
viously described (Hoevenaars et al., 2013)) and expressed as 
kcal/h. The average of all the energy expenditure values was 
taken and multiplied by 24 to obtain the energy expenditure in 
kcal/day.
2.3 | Sacrifice
At the end of the 6th week of the intervention, animals 
were food deprived for at least 2 hr during the light phase. 
A tail incision was made and blood glucose concentra-
tions were measured with a Freestyle blood glucose system 
(Abbott Diabetes Care, Hoofddorp, The Netherlands); no 
T A B L E  1  Composition of the intervention diets. Ingredients are 
given in gram/ kilogram of diet. All diets are moderate high–fat and 
isocaloric
 
Moderate-
high fat–
glucose 
(HF-G)
Moderate-
high fat–
glucose–
fructose 
(HF-GF)
Moderate-
high fat–
fructose 
(HF-F)
Casein 225 225 225
Wheat starch 172 172 172
Dextrose 322.5 161.25 0
Fructose 0 161.25 322.5
Lipidsa 180 180 180
Cholesterol 0.097 0.097 0.097
Cellulose 50 50 50
Mineral mixture 35 35 35
Vitamin mixture 10 10 10
Choline bitartrate 2.5 2.5 2.5
L-Cysteine 3 3 3
Total 1,000 1,000 1,000
Total energy (kcal) 4,510 4,510 4,510
Protein en% 20.2 20.2 20.2
CHO en% 43.9 43.9 43.9
Fat en% 35.9 35.9 35.9
aThe lipid fraction contained 18% cocos oil, 70% sunflower oil, and 12% 
flaxseed oil (wt/wt) to ensure a health fatty acid profile, as in the BIOCLAIMS 
diet [27]. 
4 of 12 |   BOUWMAN et Al.
anesthesia was used to prevent effects on blood glucose con-
centrations (Constantinides, Mean, & Janssen, 2011). Blood 
was collected in Microvette CB 300 EDTA tubes (Sarstedt, 
Nürnberg, Germany) to obtain plasma samples by centrifu-
gation at 2000g. Immediately afterwards, the animals were 
anesthetized with a mixture of 5% isoflurane in 1:1 gas mix-
ture of nitrous oxide and oxygen for 1 min, and decapitated. 
Liver and gonadal fat pads (epididymal fat pad in males and 
fat pads around uterus in females) were collected, weighed, 
snap frozen in liquid nitrogen, and stored at −80°C. The small 
intestine was collected, cut open longitudinally, rinsed, and 
scraped. Cell scrapings were snap frozen in liquid nitrogen, 
and stored at −80°C.
2.4 | Plasma measurements
Insulin concentrations were analyzed in plasma using a 
Mouse insulin (TMB) ELISA kit (Biovendor GmbH, Kassel, 
Germany) according to the manufacturer's instructions. 
Plasma triglyceride (TG) concentrations were measured 
using an Instruchemie Triglyceride Liquicolor kit (HUMAN, 
Wiesbaden, Germany). HOMA-IR was calculated from levels 
of insulin and blood glucose, using a C57BL/6J mice-adjusted 
factor of 14.1, as previously described (Dijk et al., 2013).
2.5 | Liver measurements
Liver tissue was defrosted and dissolved in Tris-EDTA 
buffer (20 mg/ml). The TG level was determined using an 
Instruchemie Triglycerides Liquicolor kit (HUMAN) accord-
ing to the manufacturer's instructions. Input was corrected for 
wet tissue weight. Liver glycogen levels were determined ac-
cording to a method previously described (Krisman, 1962). 
Briefly, liver tissue (caudate lobe) was grinded and dissolved 
in chloric acid solution (7%). Samples were centrifuged at 
830g for 15  min (4°C) and the supernatant was stored at 
−80°C for 1.5 hr. Petroleum ether was added to the frozen 
sample and after shaking, the aqueous layer was collected 
and stored on ice. A total amount of 260 μl reagent solution 
(0.90  M calcium chloride; 1.31  mM iodine; and 11.4  mM 
potassium iodine) was added to 10 μl sample. After 10 min 
incubation, the absorbance was measured at 460 nm.
2.6 | Gene expression analysis
Liver or intestinal tissue was grinded and homogenized in liq-
uid nitrogen. Subsequently, RNA was isolated using a RNeasy 
Mini Kit (Qiagen, Venlo, The Netherlands) according to 
the manufacturers’ instructions. RNA yield and purity were 
T A B L E  2  Target genes, primer sequences, and annealing temperatures in RT-qPCR
Gene Forward Primer 5′−3′ Reverse Primer 5′−3′
Annealing 
Temperature (°C)
Acacb TCTTCACGTTCAGAGCGAGGGAT ATCTTGTGGTTGGCACAGGGCA 55.6
Aldob TACCAGATACAACCCCAATAGTCAGG TCAACTCATTCTCTACACTCCATAGC 61.5
Canxa GCAGCGACCTATGATTGACAACC GCTCCAAACCAATAGCACTGAAAGG 60.0
Elovl6 GGCACTAAGACCGCAAGGCA GCTACGTGTTCTCTGCGCCT 60.0
Fasn AGTTAGAGCAGGACAAGCCCAAG GTGCAGAGCTGTGCTCCTGA 60.0
Gapdh AAGGCTGTGGGCAAGGTCATC CGAAGGTGGAAGAGTGGGAGTTG 61.5
Hk1 ACGCTCGGTGCCATCTTGAAC CCTTGCCACTGCCACTCTCC 61.5
Hk2 ATCAAAGAGAACAAGGGCGAGGAG GCGGAGGAAGCGGACATCAC 61.5
Hk4 CCTGGGCTTCACCTTCTCCTTC CCTCACATTGGCGGTCTTCATAG 61.5
Hprt1a TGACACTGGTAAAACAATGCAAACTTTG GAGGTCCTTTTCACCAGCAAGCT 61.5
Khk GCAGCGGATAGAGGAGCACAATG CCAGGCACAGACAAGCGTAGC 61.5
Mttp1 GTGGAGGAATCCTGATGGTGA TGATCTTAGGTGTACTTTTGCCC 61
Rps15a CGGAGATGGTGGGTAGCATGG ACGGGTTTGTAGGTGATGGAGAAC 60
Scd1 TCATGGTCCTGCTGCACTTGG CTGTGGCTCCAGAGGCGATG 60
Slc2a2 CACACCAGCATACACAACACCAG GGACACAGACAGAGACCAGAGC 61.5
Slc2a5 TCCTCCTCCTCCCGTTCTTTCC CTTCTCAGCCTCATCCTCCTTCC 61.5
Slc2a7 TCGGTGGTGAGGACAGAGATTG AGCAGCAGTGAGGATACAGACG 61.5
Slc5a1 TCGTCATCTACTTCGTGGTGGTG CCTGCGGCTGCTCCTGTG 61.5
Tkfc GGGCAGCAGCACAGGAGTTC AGGATGGCACGGAAGATGGC 61.5
Tpi1 GGACTGGCAAGACGGCAAC GCAGGCAGGTAGAGGGATGG 61.5
aTranscripts used for normalization. 
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evaluated using a Nanodrop Spectrophotometer (Isogen Life 
Science, Maarssen, The Netherlands) and RNA integrity was 
measured on the Experion automated electrophoresis system 
(Bio-Rad, Veenendaal, The Netherlands). cDNA was synthe-
sized using the iScript cDNA synthesis kit (Bio-Rad). Reverse-
transcription quantitative real-time polymerase chain reaction 
(RT-qPCR) experiments were performed using iQ SYBR 
Green Supermix (Bio-Rad). As regard the standard curves, se-
rial dilutions of pooled cDNA from all samples were made. 
Samples were tested in duplicate; male and female samples 
were tested in separate runs. An overview of the target genes, 
primer sequences, and annealing temperatures can be found in 
Table 2. The expression of target genes was normalized against 
the geometrical mean of the reference gene(s), and normalized 
against the mean of the glucose group set at 1.0. For intestinal 
gene expression, Ribosomal protein S15 (Rps15) and Calnexin 
(Canx) were used as reference genes. As regard the hepatic 
gene expression, Rps15 and Hypoxanthine phosphoribosyl-
transferase 1 (Hprt1) were used as reference genes for the ex-
pression of Slc2a2, Slc2a5, Hk1, Hk2, Hk4, Khk, Aldob, Tkfc, 
Gapdh, and Tpi1; Canx was used as reference gene for DNL 
genes acetyl-CoA carboxylase beta (Acacb), fatty acid syn-
thase (Fasn), elongation of long-chain fatty acids family mem-
ber 6 (Elovl6), and stearoyl-coenzyme A desaturase 1 (Scd1) 
as well as microsomal triglyceride transfer protein (Mttp1), a 
protein involved in hepatic lipid export.
2.7 | Statistical analysis
Statistical analysis was performed using GraphPad Prism 
version 5.04 (Graphpad Software, San Diego, USA). 
Comparisons were made between the different diets within 
each sex. Data were checked for normality by a D’Agostino 
& Pearson omnibus normality test. If data were not normally 
distributed, they were log converted and rechecked for nor-
mality. A one-way ANOVA with post hoc Tukey comparison 
was used for normally distributed datasets. In case of not- 
normally distributed data or unequal variances, a Kruskal–
Wallis test was performed, followed by a Dunn's Multiple 
comparison test. Bodyweight and RER curves were analyzed 
by two-way ANOVA. p-values <.05 were considered statis-
tically significant.
3 |  RESULTS
Bodyweight was not significantly different among animals 
on a moderate high–fat diet rich in glucose (HF-G), fruc-
tose (HF-F), or glucose-fructose in a 1:1 ratio (HF-GF), 
neither for males (Figure 1a) nor for females (Figure 1b). 
Only in male mice, the interaction time x diet was signifi-
cant: HF-GF males gained more bodyweight than HF-G 
males or HF-F males. Cumulative caloric intake was sig-
nificantly higher in HF-G animals compared with HF-F 
animals in both sexes (Table 3). As diets were isocaloric, 
differences in caloric intake were due to a difference in 
food intake. Animals on the HF-GF diet had an intermedi-
ate food intake.
Indirect calorimetry measurements in week 5 showed that 
mean RER values were higher in the dark phase than in the 
light phase in both males (Figure 2a, Table 3) and females 
(Figure 2b, Table3), indicating relatively more carbohydrate 
metabolism during the dark phase and more lipid metabolism 
in the light phase. However, no effect of diet on RER was 
found in either sex (Figure 2, Table 2). Twenty-four hour en-
ergy expenditure was not affected by the diet, in males as well 
as females (Table 2).
Gonadal fat pad weight was similar among HF-G, HF-GF, 
and HF-F males, suggesting no difference in adiposity at the end 
of the intervention (Table 3). Gonadal fat pad weight was also 
similar among HF-G, HF-GF, and HF-F females. Liver weight 
was not affected by diet in either sex. In males, plasma insu-
lin concentrations (p = .11) and blood glucose concentrations 
F I G U R E  1  Bodyweight development. Bodyweight development during the intervention period for males (a) and females (b) when giving 
a 35.9 en% high-fat diet containing 28.6 en% of glucose (HF-G, solid dots and lines), 14.3 en%-14.3 en% glucose and fructose (HF-GF, half-open 
dots and striped lines), or 28.6en% fructose (HF-F, open dots and dotted lines). Values are expressed as mean ± SEM; n = 10
a b
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(p = .20) did not differ significantly among groups (Figure 3a 
and b). As a consequence, HOMA-IR was not significantly 
different (p =  .11; Figure 3c). For the females, plasma insu-
lin concentrations were not different among the diets (Figure 
3d; p = .42), and although a trend was observed for the HF-F 
females to have a lower blood glucose concentrations than 
the HF-G females (Figure 3e), this effect was not significant 
(p = .054). HOMA-IR index was not significantly affected by 
the diet in females (Figure 3f; p = .41). Overall, this suggests 
no effect on glucose homeostasis by the diet in both sexes.
T A B L E  3  Food intake, energy expenditure, RER, and organ weights. The cumulative caloric intake is calculated over the 6 weeks 
experimental period
   
Cumulative feed 
intake (g)
Energy 
expenditure 
(kcal/day)
Average RER 
(dark phase)
Average RER 
(light phase)
Gonadal fat pad 
weight (g) Liver weight (g)
Males HF-G 149 ± 10a 12.55 ± 0.53 0.86 ± 0.02 0.80 ± 0.03 1.95 ± 0.29 1.43 ± 0.15
HF-GF 146 ± 8a,b 13.10 ± 0.61 0.86 ± 0.02 0.83 ± 0.03 2.12 ± 0.33 1.52 ± 0.21
HF-F 140 ± 8b 12.82 ± 0.41 0.87 ± 0.02 0.82 ± 0.03 2.07 ± 0.40 1.50 ± 0.12
Females HF-G 156 ± 10x 11.93 ± 0.66 0.88 ± 0.06 0.82 ± 0.06 1.35 ± 0.46 1.10 ± 0.15
HF-GF 150 ± 13x,y 11.93 ± 0.52 0.90 ± 0.04 0.82 ± 0.04 1.33 ± 0.50 1.13 ± 0.12
HF-F 138 ± 19y 11.69 ± 0.59 0.91 ± 0.04 0.85 ± 0.05 1.13 ± 0.34 1.14 ± 0.16
Note: The mean energy expenditure is calculated over a 24-hr period in the indirect calorimetry system. The mean respiratory exchange ratio (RER) is calculated over 
a 10-hr (light phase) or 12-hr (dark phase) period. Gonadal fat pad weight and liver weight were measured at sacrifice. Different superscript letters indicate significant 
differences (p < .05), data are analyzed within sex. Values are expressed as mean ± SD, n = 10.
F I G U R E  2  Mean Respiratory 
Exchange Ratio (RER) over a 24-hr period. 
RER was measured by indirect calorimetry, 
in male (a) and in female (b) mice. The 
grey shaded area represents the dark phase 
(when animals are active), and the white 
shaded areas represent the light phase (when 
animals are inactive). Solid lines represent 
HF-G, striped lines represent HF-GF, and 
dotted lines represent HF-F; lines show 
mean of the group (n = 10)
a
b
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Plasma TG concentrations were significantly higher in 
HF-F males compared with HF-G males, with intermediate 
TG concentrations in HF-GF male mice (Figure 4a). HF-GF 
females had significantly higher plasma TG concentrations 
than HF-G and HF-F females (Figure 4c). In contrast to 
plasma TG concentrations, total hepatic TG content was not 
affected by diet (Figure 4b for males, d for females). Hepatic 
glycogen levels did not differ among the diets in both sexes 
(data not shown).
The mRNA expression of the fructose-related enzyme 
ketohexokinase (Khk) was increased in both fructose-fed 
male groups (HF-GF and HF-F) (Figure 5a). Hexokinase 4 
(Hk4) was the only hexokinase for which the expression was 
significantly increased in the HF-F males compared with 
HF-G males, while the expression of other hexokinases was 
not affected. The fructose content of the diet did not alter the 
hepatic expression of monosaccharide transporters (Slc2a2 
and Slc2a5), DNL-related enzymes (Acacb, Elovl6, Fasn and 
Scd1), and Mttp1 in males; of the glycolysis-related enzymes 
(AldoB, Gapdh, Tkfc, and Tpi) only AldoB expression was 
significantly higher in HF-F males than in HF-G males. A 
significant upregulation of Slc2a5 was found in the HF-GF 
females compared with HF-F females (Figure 5b). Hk1 was 
downregulated in the HF-F females compared with the HF-G 
females and HF-GF females. The hepatic expression of other 
kinases (Hk2, Hk4, and Khk) and Slc2a2 was not affected by 
F I G U R E  3  Plasma insulin, blood glucose, and HOMA -IR. Plasma insulin concentrations in male (a) and female (d) mice, blood glucose 
concentrations in males (b) and females (e), and HOMA-IR in males (c) and females (f). Solid bars represent HF-G diet, striped bars represent HF-
GF, and white bars represent HF-F. Values are expressed as mean ± SEM, n = 10 or n = 8 (HF-G males insulin and HF-G males HOMA-IR)
a
d e f
b c
F I G U R E  4  Plasma TG concentrations 
and hepatic TG levels. Plasma TG 
concentrations in male (a) and female (c) 
mice. Liver TG levels in males (b) and 
females (d). Solid bars represent HF-G 
diet, striped bars represent HF-GF, and 
white bars represent HF-F. Values are 
expressed as mean ± SEM, n = 8 for the 
plasma measurement in the HF-G male 
group, n = 10 for all other groups. *p < .05; 
**p < .01
a
c d
b
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the fructose content of the diet in females, or were glycoly-
sis-related enzymes or Mttp1. DNL-related enzyme expres-
sion was not significantly altered, except for a higher Scd1 
expression in HF-F females compared with HF-G females.
Finally, intestinal gene expression was studied in the fe-
males. No significant changes were observed in the expression 
of sugar transporters (Slc2a2, Slc2a5, Slc2a7, and Slc5a1), 
hexokinases, or glycolysis-related enzymes (Figure 6).
4 |  DISCUSSION
Animals fed a Westernized moderate high–fat diet in which 
half or all of the dietary monosaccharide glucose was re-
placed with fructose did not show altered HF-induced 
bodyweight or adiposity, neither in males nor in females. 
Nevertheless, plasma TG concentrations were affected by 
the fructose content, as HF-F males had higher TG concen-
trations than HF-G males, and HF-GF females had higher 
plasma TG concentrations than HF-G and HF-F females. 
Liver TG and glycogen levels were not altered by the di-
etary fructose. From these data we conclude that medium- 
to long-term isocaloric replacement of dietary glucose with 
dietary fructose does not affect body composition or liver 
energy stores. These data are in line with a meta-analysis 
in humans, isocaloric studies concluding that fructose has 
no more effect on bodyweight than other carbohydrates 
(Sievenpiper et al., 2012). The same group reported that 
fructose intake, compared with glucose intake, can increase 
circulating uric acid and TG concentrations, but does not 
worsen insulin concentrations, markers of fatty liver, or 
atherogenic aspects of the lipid profile (Sievenpiper et al., 
2014). Fructose may even have positive effects on body-
weight and blood pressure in human intervention studies 
(Sievenpiper et al., 2014). This fully agrees with our ob-
servation that plasma TG concentrations were increased by 
the fructose content in the diet, especially in the combined 
fructose–glucose exposure. Nevertheless, postprandial 
plasma TG is particularly influenced under hypocaloric 
conditions, and not in case of isocaloric replacement, as 
F I G U R E  5  Hepatic gene expression. Expression of enzymes involved in monosaccharide transport, initial glucose conversion (hexokinases), 
glycolysis, de novo lipogenesis, and lipid transport in liver tissue for (a) male and (b) female mice. Acacb: Acetyl-CoA carboxylase beta; Aldob: 
Aldolase B; Elovl6: Elongation of long-chain fatty acids family member 6; Fasn: Fatty acid synthase; Gapdh: Glyceraldehyde-3-phosphate 
dehydrogenase; Hk: Hexokinase; Khk: Ketohexokinase; Mttp: Microsomal triglyceride transfer protein; Scd1: Stearoyl-coenzyme A desaturase 1; 
Slc2a: Solute Carrier Family 2; Tkfc: Triokinase, FMN cyclase; Tpi: Triose phosphate isomerase. Solid dots represent HF-G diet, half-open dots 
represent HF-GF, and open dots represent HF-F. Values are expressed as mean ± SEM, n = 9–10. *p < .05; **p < .01; ***p < .001
a
b
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was shown in another meta-analysis of human intervention 
trials (Wang et al., 2014).
Here, we chose to use an intervention period of 6 weeks. 
For the analysis of hepatic metabolism and respiratory ex-
change ratio measurements, as performed with indirect 
calorimetry, this period suffices as differences will arise im-
mediately. In addition, in this mouse strain, an intervention pe-
riod of 5 weeks was sufficient for stabilization of bodyweight 
upon switches between high- and low-fat diet (Hoevenaars 
et al., 2013), and upon moderate caloric restriction of me-
dium-high–fat diets (Duivenvoorde, Schothorst, Bunschoten, 
& Keijer, 2011; Palm, Schram, Swarts, Schothorst, & Keijer, 
2017). Therefore, we consider the intervention period as 
sufficiently long, although it should be emphasized that our 
conclusions on BW and food intake are for a medium-to long-
term period.
Our data are in striking contrast to other studies that 
show increased adiposity, increased liver weight, and in-
creased hepatic TG levels resulting from fructose intake. In 
the large majority of cases, these effects can be explained 
by excess caloric intake, in particular due to supplemen-
tation with fructose via the drinking water or the lack of 
an adequate control group (Koricanac et al., 2013; Spruss 
et al., 2012; Vilà et al., 2011). Effects of fructose feeding 
mimic those of high-fat feeding (Ren et al., 2012; Song 
et al., 2012). In addition, fructose can exaggerate the obe-
sogenic effects of high-fat diet and promote insulin resis-
tance (Crescenzo et al., 2015, 2014). It is not clear whether 
these effects are fructose specific, or that similar effects 
would be seen with glucose. Indeed, also maltodextrin ex-
aggerates the effects of a high-fat diet (Mei et al., 2014). 
With similar caloric intake, fructose administered via the 
drinking water gives worse metabolic outcomes than glu-
cose administered via the drinking water in animals on a 
high-fat diet (Softic et al., 2017). The overall macronutrient 
intake was also shifted to some extend in that study (Softic 
et al., 2017). Nevertheless, overfeeding with fructose bev-
erages in overweight human subjects leads to an increase 
in visceral adipose tissue and more DNL than overfeed-
ing with glucose beverages (Stanhope et al., 2009). In our 
study, fructose and glucose were administered as part of 
the pelletized diet in an isocaloric manner, to circumvent 
the confounding effects of overconsumption of fructose in 
the drinking water, and to prevent shifts in macronutrient 
intake. Although overconsumption and shifts in macronu-
trient intake were prevented, the fructose diet displayed a 
significantly lower energy intake in both sexes: HF-F males 
consumed 6% less than HF-G males, whereas HF-F females 
consumed 12% less than HF-G females. Our data contrast 
with a study where normal-fat diets with 18% of energy 
from fructose or from glucose were to young male mice, 
resulting in increased bodyweight, liver weight, and fat 
mass by fructose compared with glucose (Rendeiro et al., 
2015). Of importance, also the absolute caloric intake was 
higher in the fructose group, despite isocaloric amounts 
of the sugars in the experimental diets. The overall lower 
caloric intake may have had some protective influence in 
our study. Taken together, outcomes of studies seem to be 
affected by overall energy intake and by manner of fruc-
tose administration (as part of the diet of in a liquid).
To substantiate potential functional differences among 
fructose, glucose–fructose, and glucose, hepatic gene ex-
pression was analyzed, which showed minor changes. The 
upregulation of KHK in HF-GF and HF-F compared with 
F I G U R E  6  Intestinal gene expression in female mice. Expression of enzymes involved in monosaccharide transport, initial glucose 
conversion (hexokinases), and glycolysis in the intestinal tissue of female mice. Aldob: Aldolase B; Gapdh: Glyceraldehyde-3-phosphate 
dehydrogenase; Hk: Hexokinase; Khk: Ketohexokinase; Slc2a: Solute Carrier Family 2; Slc5a: Solute Carrier Family 5; Tpi: Triose phosphate 
isomerase. Solid dots represent HF-G diet, half-open dots represent HF-GF, and open dots represent HF-F. Data were with a one-way ANOVA 
on original (Hk2, Aldob, Gapdh, and Tpi) or log-transformed data (Slc2a2, Slc2a5, Slc2a7, Slc5a1, Hk, and Khk). Values are expressed as 
mean ± SEM, n = 10
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the HF-G was significant in males, and may be expected 
as KHK is the first enzyme metabolizing cellular fructose. 
The limited effect size in other genes may be due to the 
timing of the analysis: lipogenesis-related gene expression 
in liver was upregulated after 5  days of fructose feeding 
compared with a starch control, but the difference did not 
persist after 45  days of fructose feeding (Polakof et al., 
2016). Alternatively, because the animals were killed in the 
daytime, 2 hr after removal of the diets, they were possibly 
in the postprandial state, which may have limited the gene 
expression effects of fructose. However, this argument is 
counteracted by the observed upregulation of Slc5a2 in 
HF-GF–fed males and females. The absence of pronounced 
gene expression effects is in agreement with the absence 
of differential effects of the monosaccharides on body and 
liver composition.
Our results did show increased plasma TG concentrations 
with fructose in the diet (Figure 4). Because hepatic gene ex-
pression did not indicate an increase in DNL, these increased 
concentrations may result from decreased clearance. In fact, 
decreased lipid clearance can be caused by sucrose (Grant, 
Marais, & Dhansay, 1994) and fructose (Jeppesen et al., 
1995). Increased circulating TG with fructose in the diet was 
also seen in human males (Bantle et al., 2000; Goff, Whyte, 
Samuel, & Harding, 2016), but not in females (Bantle et al., 
2000). Moreover, as in our study, no differential effects on he-
patic TG levels were seen in humans with 25 energy percent 
from glucose or from fructose, neither with isocaloric feeding 
nor hypocaloric feeding (Johnston et al., 2013). The absence 
of a difference between glucose and fructose, but higher he-
patic TG levels in the hypercaloric condition compared with 
the isocaloric condition confirm the notion that it is particu-
larly the energy intake, rather than specific effects of fructose 
compared with glucose that results in the adverse metabolic 
effects. Indeed, a recent human study showed also overall lack 
of effects by high fructose intake (Smajis et al., 2019).
In summary, our physiological data indicate that, within 
an isocaloric pelletized diet, in the medium-long–term fruc-
tose does not result in worse physiological effects than glu-
cose or glucose–fructose.
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